{"id":"https://openalex.org/W1994398288","doi":"https://doi.org/10.1177/1403494810379290","title":"Evaluation of the long-term cost-effectiveness of insulin detemir compared with neutral protamine hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in Sweden","display_name":"Evaluation of the long-term cost-effectiveness of insulin detemir compared with neutral protamine hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in Sweden","alternate_titles":[],"publication_year":2010,"publication_date":"2010-08-05","ids":{"openalex":"https://openalex.org/W1994398288","doi":"https://doi.org/10.1177/1403494810379290","mag":"1994398288","pmid":"https://pubmed.ncbi.nlm.nih.gov/20688795"},"language":"en","primary_location":{"id":"doi:10.1177/1403494810379290","doi":"https://doi.org/10.1177/1403494810379290","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1403494810379290","pdf_url":null,"source":{"id":"https://openalex.org/S163542868","display_name":"Scandinavian Journal of Public Health","issn_l":"1403-4948","issn":["1403-4948","1651-1905"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scandinavian Journal of Public Health","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1994398288"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037654589","display_name":"William J. Valentine","orcid":"https://orcid.org/0000-0003-4844-6813","observed_orcids":["https://orcid.org/0000-0003-4844-6813"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"William J. Valentine","raw_affiliation_strings":["Ossian Health Economics and Communication, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ossian Health Economics and Communication, Basel, Switzerland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005052359","display_name":"Mark Aagren","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark Aagren","raw_affiliation_strings":["Novo Nordisk Inc., Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk Inc., Princeton, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mattias Haglund","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mattias Haglund","raw_affiliation_strings":["Novo Nordisk Scandinavia AB, Malm\u00f6, Sweden, NeuroSearch A/S, Ballerup, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk Scandinavia AB, Malm\u00f6, Sweden, NeuroSearch A/S, Ballerup, Denmark","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035244584","display_name":"\u00c5sa Ericsson","orcid":"https://orcid.org/0000-0002-3226-7469","observed_orcids":["https://orcid.org/0000-0002-3226-7469"]},"institutions":[{"id":"https://openalex.org/I4405268700","display_name":"Novo Nordisk Canada (Canada)","ror":"https://ror.org/01th56526","country_code":"CA","type":"company","lineage":["https://openalex.org/I4405268700"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"\u00c5sa Ericsson","raw_affiliation_strings":["Novo Nordisk Scandinavia AB, Malm\u00f6, Sweden","Novo Nordisk Scandinavia AB, Malmo, Sweden;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk Scandinavia AB, Malm\u00f6, Sweden","institution_ids":[]},{"raw_affiliation_string":"Novo Nordisk Scandinavia AB, Malmo, Sweden;","institution_ids":["https://openalex.org/I4405268700"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088273834","display_name":"MH Gschwend","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108991","display_name":"IQVIA (United States)","ror":"https://ror.org/01mk44223","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108991"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Manuela H. Gschwend","raw_affiliation_strings":["IMS Health, Basel, Switzerland,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IMS Health, Basel, Switzerland,","institution_ids":["https://openalex.org/I4210108991"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":1.2479,"has_fulltext":false,"cited_by_count":36,"citation_normalized_percentile":{"value":0.788993,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"39","issue":"1","first_page":"79","last_page":"87"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.6640999913215637,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.6640999913215637,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.27709999680519104,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.0414000004529953,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/insulin-detemir","display_name":"insulin detemir","score":0.9959999918937683},{"id":"https://openalex.org/keywords/nph-insulin","display_name":"NPH insulin","score":0.8640000224113464},{"id":"https://openalex.org/keywords/type-1-diabetes","display_name":"type 1 diabetes","score":0.9900000095367432},{"id":"https://openalex.org/keywords/multiple-daily-injections","display_name":"multiple daily insulin injections","score":0.902999997138977},{"id":"https://openalex.org/keywords/insulin-aspart","display_name":"insulin aspart","score":0.9570000171661377},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.902999997138977},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.7739999890327454},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.875},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8939999938011169},{"id":"https://openalex.org/keywords/life-expectancy","display_name":"life expectancy","score":0.722000002861023},{"id":"https://openalex.org/keywords/diabetes-complications","display_name":"diabetes complications","score":0.5950000286102295},{"id":"https://openalex.org/keywords/indirect-costs","display_name":"indirect costs","score":0.5609999895095825},{"id":"https://openalex.org/keywords/sweden","display_name":"Sweden","score":0.3799999952316284},{"id":"https://openalex.org/keywords/economic-evaluation","display_name":"economic evaluation","score":0.3490000069141388},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.5130000114440918},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.7929999828338623}],"concepts":[{"id":"https://openalex.org/C2780677441","wikidata":"https://www.wikidata.org/wiki/Q410965","display_name":"Insulin detemir","level":5,"score":0.9360817670822144},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8523051142692566},{"id":"https://openalex.org/C2778804033","wikidata":"https://www.wikidata.org/wiki/Q1929845","display_name":"NPH insulin","level":5,"score":0.8315849304199219},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5334041118621826},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5215163826942444},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5110874772071838},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5035251975059509},{"id":"https://openalex.org/C2779908123","wikidata":"https://www.wikidata.org/wiki/Q2754775","display_name":"Insulin aspart","level":4,"score":0.47721534967422485},{"id":"https://openalex.org/C2779920387","wikidata":"https://www.wikidata.org/wiki/Q417317","display_name":"Insulin glargine","level":4,"score":0.46494948863983154},{"id":"https://openalex.org/C2781232474","wikidata":"https://www.wikidata.org/wiki/Q124407","display_name":"Type 1 diabetes","level":3,"score":0.4254534840583801},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.39136505126953125},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3866994380950928}],"mesh":[{"descriptor_ui":"D000069057","descriptor_name":"Insulin Detemir","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D007336","descriptor_name":"Insulin, Isophane","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007336","descriptor_name":"Insulin, Isophane","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013548","descriptor_name":"Sweden","qualifier_ui":"Q000208","qualifier_name":"ethnology","is_major_topic":false},{"descriptor_ui":"D013548","descriptor_name":"Sweden","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017048","descriptor_name":"Health Care Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017063","descriptor_name":"Outcome Assessment, Health Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017281","descriptor_name":"Cost of Illness","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019057","descriptor_name":"Quality-Adjusted Life Years","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048909","descriptor_name":"Diabetes Complications","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D048909","descriptor_name":"Diabetes Complications","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D048909","descriptor_name":"Diabetes Complications","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D049528","descriptor_name":"Insulin, Long-Acting","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/1403494810379290","doi":"https://doi.org/10.1177/1403494810379290","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1403494810379290","pdf_url":null,"source":{"id":"https://openalex.org/S163542868","display_name":"Scandinavian Journal of Public Health","issn_l":"1403-4948","issn":["1403-4948","1651-1905"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scandinavian Journal of Public Health","raw_type":"journal-article"},{"id":"pmid:20688795","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20688795","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scandinavian journal of public health","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9907000064849854}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W204414647","https://openalex.org/W1752045965","https://openalex.org/W1939277701","https://openalex.org/W1963607458","https://openalex.org/W1970898198","https://openalex.org/W1986931072","https://openalex.org/W1988959682","https://openalex.org/W1992855175","https://openalex.org/W1999789157","https://openalex.org/W2007605927","https://openalex.org/W2020572030","https://openalex.org/W2038962843","https://openalex.org/W2039342460","https://openalex.org/W2057581868","https://openalex.org/W2064303441","https://openalex.org/W2087273473","https://openalex.org/W2095171970","https://openalex.org/W2111916699","https://openalex.org/W2111938541","https://openalex.org/W2115209313","https://openalex.org/W2117191092","https://openalex.org/W2125788080","https://openalex.org/W2129121181","https://openalex.org/W2139618761","https://openalex.org/W2145153425","https://openalex.org/W2169355652","https://openalex.org/W2520696266","https://openalex.org/W2769264260","https://openalex.org/W4236501586"],"related_works":["https://openalex.org/W2166558251","https://openalex.org/W2131902279","https://openalex.org/W1963607458","https://openalex.org/W2016331296","https://openalex.org/W1959317204","https://openalex.org/W2128634238","https://openalex.org/W1978467870","https://openalex.org/W2804093525","https://openalex.org/W3021145384","https://openalex.org/W2175837456"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"evaluate":[2],"the":[3,193],"long-term":[4],"clinical":[5],"and":[6,13,68,100,116,121,147,178,260],"economic":[7],"outcomes":[8],"associated":[9,48],"with":[10,21,27,49,82,127,246,268],"insulin":[11,18,23,128,194,222,248],"detemir":[12,46,83,129,195,223,249],"neutral":[14],"protamine":[15],"hagedorn":[16],"(NPH)":[17],"in":[19,25,31,52,168,192,266,272],"combination":[20],"mealtime":[22],"aspart":[24],"patients":[26,267],"type":[28,269],"1":[29,270],"diabetes":[30,271],"Sweden,":[32],"based":[33],"on":[34,95],"data":[35],"from":[36,255,262],"a":[37,98,256,263],"two-year,":[38],"multi-national,":[39],"open-label,":[40],"randomized,":[41],"controlled":[42],"trial.":[43],"METHODS:":[44],"Insulin":[45],"was":[47,108,130],"significant":[50],"improvements":[51],"glycaemic":[53],"control":[54],"after":[55],"24":[56],"months":[57],"(HbA1c":[58],"7.36%":[59],"versus":[60,78,88,142,157,162,201,240],"7.58%,":[61],"mean":[62],"difference":[63],"-0.22%,":[64],"p":[65,75],"=":[66,76,92],"0.022)":[67],"major":[69],"hypoglycaemic":[70,180],"events":[71],"(69%":[72],"risk":[73],"reduction,":[74],"0.001)":[77],"NPH.":[79],"Patients":[80],"treated":[81],"gained":[84],"less":[85],"weight":[86],"(1.7":[87],"2.7":[89],"kg,":[90],"P":[91],"0.024).":[93],"Based":[94],"these":[96],"findings,":[97],"published":[99],"validated":[101],"computer":[102],"model":[103],"(IMS":[104],"CORE":[105],"Diabetes":[106],"Model)":[107],"used":[109],"to":[110,132,206,221,234,252],"estimate":[111],"life-expectancy,":[112],"quality-adjusted":[113,148,153],"life":[114,134,149,154],"expectancy":[115,135,150],"both":[117],"direct":[118],"medical":[119,183],"costs":[120,184,219],"indirect":[122,218],"costs.":[123],"RESULTS:":[124],"Basal-bolus":[125],"therapy":[126],"projected":[131],"improve":[133],"by":[136,151,172,230],"0.14":[137],"years":[138,155],"(15.02":[139],"\u00b1":[140,144,160,164,199,203,238,242],"0.19":[141],"14.88":[143],"0.18":[145],"years)":[146],"0.53":[152],"(QALYs)":[156],"NPH":[158,235],"(8.35":[159],"0.11":[161],"7.82":[163],"0.10":[165],"QALYs).":[166],"Improvements":[167],"QALYs":[169],"were":[170,188],"driven":[171],"avoided":[173],"or":[174],"delayed":[175],"diabetes-related":[176],"complications":[177],"fewer":[179],"events.":[181],"Direct":[182],"over":[185,227],"patient":[186,228],"lifetimes":[187],"SEK":[189,212,231],"26,144":[190],"higher":[191],"arm":[196],"(SEK":[197,236],"995,025":[198],"19,580":[200],"968,881":[202],"19,769),":[204],"leading":[205],"an":[207],"incremental":[208],"cost-effectiveness":[209],"ratio":[210],"of":[211],"49,757":[213],"per":[214],"QALY":[215],"gained.":[216],"Capturing":[217],"led":[220],"being":[224],"cost":[225],"saving":[226],"lifetimes,":[229],"80,113,":[232],"compared":[233],"2,959,909":[237],"64,727":[239],"3,040,022":[241],"62,317).":[243],"CONCLUSIONS:":[244],"Compared":[245],"NPH,":[247],"is":[250],"likely":[251],"be":[253],"cost-effective":[254],"healthcare":[257],"payer":[258],"perspective":[259,265],"dominant":[261],"societal":[264],"Sweden.":[273]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1994398288","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
